NPPB and Hyperkalemia: It showed that Finerenone at doses of 5 and 10 mg daily reduced biomarkers like BNP, NT-proBNP, and albuminuria as effectively, or better than, spironolactone, with fewer incidents of hyperkalemia and less renal function decline, suggesting a superior safety profile [26].